Flu Vaccine Market Research: Global Status & Forecast by Geography, Type & Application (2015-2025)
June 2019
69
About the Report
About the Report
According to 99Strategy, the Global Flu Vaccine Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Flu Vaccine market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
AstraZeneca
CSL Limited
GSK
Hualun Biologicalsamong
ID Biomedical Corporation
Johnson & Johnson
MedImmune, LLC
Mylan
Novartis
Pfizer
Protein Sciences Corporaton
Sanofi Pasteur
Serum Institute of India
Sinovac Biotech
Key Product Type
Fluzone/Vaxigrip
Anflu
FluMist
Fluarix
FluLaval
Fluvax/Afluria
Fluvirin
Others
Market by Influenza Viruses
Influenza A viruses
Influenza B viruses
Others
Market by Application
Pediatrics
Adults
Main Aspects covered in the Report
Overview of the Flu Vaccine market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development
Products
Table of Contents
Table of Contents
Table of Content
1 Industrial Chain Overview
1.1 Flu Vaccine Industry
1.1.1 Overview
1.1.2 Characteristics of Flu Vaccine
1.2 Upstream
1.2.1 Major Materials
1.2.2 Manufacturing Overview
1.3 Product List By Ofvaccines
1.3.1 Fluzone/Vaxigrip
1.3.2 Anflu
1.3.3 FluMist
1.3.4 Fluarix
1.3.5 FluLaval
1.3.6 Fluvax/Afluria
1.3.7 Fluvirin
1.3.8 Others
1.4 Product List By Influenza Viruses
1.4.1 Influenza A viruses
1.4.2 Influenza B viruses
1.4.3 Others
1.5 End-Use List
1.5.1 Demand in Pediatrics
1.5.2 Demand in Adults
1.6 Global Market Overview
1.6.1 Global Market Size and Forecast, 2015-2025
1.6.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
1.6.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
1.6.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025
2 Global Production & Consumption by Geography
2.1 Global Production & Consumption
2.1.1 Global Production
2.1.2 Global Consumption
2.2 Geographic Production & Consumption
2.2.1 Production
2.2.1.1 Asia-Pacific
2.2.1.2 North America
2.2.1.3 South America
2.2.1.4 Europe
2.2.1.5 Middle East & Africa
2.2.2 Consumption
2.2.2.1 Asia-Pacific
2.2.2.2 North America
2.2.2.3 South America
2.2.2.4 Europe
2.2.2.5 Middle East & Africa
3 Major Manufacturers Introduction
3.1 Manufacturers Overview
3.2 Manufacturers List
3.2.1 AstraZeneca Overview
3.2.1.1 Product Specifications
3.2.1.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.1.3 Recent Developments
3.2.1.4 Future Strategic Planning
3.2.2 CSL Limited Overview
3.2.2.1 Product Specifications
3.2.2.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.2.3 Recent Developments
3.2.2.4 Future Strategic Planning
3.2.3 GSK Overview
3.2.3.1 Product Specifications
3.2.3.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.3.3 Recent Developments
3.2.3.4 Future Strategic Planning
3.2.4 Hualun Biologicalsamong Overview
3.2.4.1 Product Specifications
3.2.4.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.4.3 Recent Developments
3.2.4.4 Future Strategic Planning
3.2.5 ID Biomedical Corporation Overview
3.2.5.1 Product Specifications
3.2.5.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.5.3 Recent Developments
3.2.5.4 Future Strategic Planning
3.2.6 Johnson & Johnson Overview
3.2.6.1 Product Specifications
3.2.6.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.6.3 Recent Developments
3.2.6.4 Future Strategic Planning
3.2.7 MedImmune, LLC Overview
3.2.7.1 Product Specifications
3.2.7.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.7.3 Recent Developments
3.2.7.4 Future Strategic Planning
3.2.8 Mylan Overview
3.2.8.1 Product Specifications
3.2.8.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.8.3 Recent Developments
3.2.8.4 Future Strategic Planning
3.2.9 Novartis Overview
3.2.9.1 Product Specifications
3.2.9.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.9.3 Recent Developments
3.2.9.4 Future Strategic Planning
3.2.10 Pfizer Overview
3.2.10.1 Product Specifications
3.2.10.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.10.3 Recent Developments
3.2.10.4 Future Strategic Planning
3.2.11 Protein Sciences Corporaton Overview
3.2.11.1 Product Specifications
3.2.11.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.11.3 Recent Developments
3.2.11.4 Future Strategic Planning
3.2.12 Sanofi Pasteur Overview
3.2.12.1 Product Specifications
3.2.12.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.12.3 Recent Developments
3.2.12.4 Future Strategic Planning
3.2.13 Serum Institute of India Overview
3.2.13.1 Product Specifications
3.2.13.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.13.3 Recent Developments
3.2.13.4 Future Strategic Planning
3.2.14 Sinovac Biotech Overview
3.2.14.1 Product Specifications
3.2.14.2 Business Data (Production Amount (Million USD), Cost, Margin)
3.2.14.3 Recent Developments
3.2.14.4 Future Strategic Planning
4 Market Competition Pattern
4.1 Market Size and Sketch
4.2 Company Market Share
4.2.1 Global Production by Major Manufacturers
4.2.2 Market Concentration Analysis
4.3 Market News and Trend
4.3.1 Merger & Acquisition
4.3.2 New Product Launch
5 Product Type Segment
5.1 Global Overview by Product Type Segment
5.2 Segment Subdivision by Ofvaccines
5.2.1 Market in Fluzone/Vaxigrip
5.2.1.1 Market Size
5.2.1.2 Situation & Development
5.2.2 Market in Anflu
5.2.2.1 Market Size
5.2.2.2 Situation & Development
5.2.3 Market in FluMist
5.2.3.1 Market Size
5.2.3.2 Situation & Development
5.2.4 Market in Fluarix
5.2.4.1 Market Size
5.2.4.2 Situation & Development
5.2.5 Market in FluLaval
5.2.5.1 Market Size
5.2.5.2 Situation & Development
5.2.6 Market in Fluvax/Afluria
5.2.6.1 Market Size
5.2.6.2 Situation & Development
5.2.7 Market in Fluvirin
5.2.7.1 Market Size
5.2.7.2 Situation & Development
5.2.8 Market in Others
5.2.8.1 Market Size
5.2.8.2 Situation & Development
5.3 Segment Subdivision by Influenza Viruses
5.3.1 Market in Influenza A viruses
5.3.1.1 Market Size
5.3.1.2 Situation & Development
5.3.2 Market in Influenza B viruses
5.3.2.1 Market Size
5.3.2.2 Situation & Development
5.3.3 Market in Others
5.3.3.1 Market Size
5.3.3.2 Situation & Development
6 End-Use Segment
6.1 Global Overview by End-Use Segment
6.2 Segment Subdivision
6.2.1 Market in Pediatrics
6.2.1.1 Market Size
6.2.1.2 Situation & Development
6.2.2 Market in Adults
6.2.2.1 Market Size
6.2.2.2 Situation & Development
7 Market Forecast & Trend
7.1 Regional Forecast
7.2 Consumption Forecast
7.2.1 Product Type Forecast by Ofvaccines
7.2.2 Product Type Forecast by Influenza Viruses
7.2.3 End-Use Forecast
7.3 Investment Trend
7.4 Consumption Trend
8 Price & Channel
8.1 Price and Cost
8.1.1 Price
8.1.2 Cost
8.2 Channel Segment
9 Market Drivers & Investment Environment
9.1 Market Drivers
9.2 Investment Environment
10 Research Conclusion
List of Figure
Figure Flu Vaccine Picture List
Figure Global Market Size and Forecast with Growth Rate, 2015-2025
Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD
Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD
Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD
Figure Global Production Amount Share by Manufacturers in 2019, in Million USD
Figure Global Market Amount and Growth Rate in Fluzone/Vaxigrip, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Anflu, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in FluMist, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Fluarix, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in FluLaval, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Fluvax/Afluria, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Fluvirin, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Influenza A viruses, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Influenza B viruses, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Others, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Pediatrics, 2015-2018, in USD Million
Figure Global Market Amount and Growth Rate in Adults, 2015-2018, in USD Million
List of Table
Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025 Table Global Market Size and Forecast by Ofvaccines with Growth Rate, 2015-2025 Table Global Market Size and Forecast by Influenza Viruses with Growth Rate, 2015-2025 Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025 Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD Table Major Manufacturers Headquarters and Contact Information Table Major Manufacturers Production Amount List in 2018 Table AstraZeneca Overview List Table Flu Vaccine Business Operation of AstraZeneca (Production Amount (Million USD), Cost, Gross Margin) Table CSL Limited Overview List Table Flu Vaccine Business Operation of CSL Limited (Production Amount (Million USD), Cost, Gross Margin) Table GSK Overview List Table Flu Vaccine Business Operation of GSK (Production Amount (Million USD), Cost, Gross Margin) Table Hualun Biologicalsamong Overview List Table Flu Vaccine Business Operation of Hualun Biologicalsamong (Production Amount (Million USD), Cost, Gross Margin) Table ID Biomedical Corporation Overview List Table Flu Vaccine Business Operation of ID Biomedical Corporation (Production Amount (Million USD), Cost, Gross Margin) Table Johnson & Johnson Overview List Table Flu Vaccine Business Operation of Johnson & Johnson (Production Amount (Million USD), Cost, Gross Margin) Table MedImmune, LLC Overview List Table Flu Vaccine Business Operation of MedImmune, LLC (Production Amount (Million USD), Cost, Gross Margin) Table Mylan Overview List Table Flu Vaccine Business Operation of Mylan (Production Amount (Million USD), Cost, Gross Margin) Table Novartis Overview List Table Flu Vaccine Business Operation of Novartis (Production Amount (Million USD), Cost, Gross Margin) Table Pfizer Overview List Table Flu Vaccine Business Operation of Pfizer (Production Amount (Million USD), Cost, Gross Margin) Table Protein Sciences Corporaton Overview List Table Flu Vaccine Business Operation of Protein Sciences Corporaton (Production Amount (Million USD), Cost, Gross Margin) Table Sanofi Pasteur Overview List Table Flu Vaccine Business Operation of Sanofi Pasteur (Production Amount (Million USD), Cost, Gross Margin) Table Serum Institute of India Overview List Table Flu Vaccine Business Operation of Serum Institute of India (Production Amount (Million USD), Cost, Gross Margin) Table Sinovac Biotech Overview List Table Flu Vaccine Business Operation of Sinovac Biotech (Production Amount (Million USD), Cost, Gross Margin) Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD Table Global Market Forecast by Region Segment 2019-2025, in Million USD Table Global Market Amount by Ofvaccines Segment 2019-2025, in Million USD Table Global Market Amount by End-Use Segment 2019-2025, in Million USD
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.